Sr. VP of Clinical Development · SOLENO THERAPEUTICS INC · Common Stock
Side
SELL
Value
$128K
Shares
4,256
Price
$30.04
Executed
Mar 27, 2026
Disclosed
Mar 31, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Mar 27 executedMar 31, 2026 disclosed
SLNO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Huang Michael F. filed this Form 4 reporting a open-market sale of SLNO on Mar 27, 2026. It became public on Mar 31, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Sr. VP of Clinical Development
Huang Michael F.cik:0002019992
Issuer
SOLENO THERAPEUTICS INCcik:0001484565
Revision history · 0
No field has changed since this record was first ingested.
Company events
No records
No material filings recorded for this issuer.
Source error
Price history for SLNO is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
